Theme: Enhancing Effective Execution of Nano Regulations
Track 1: Regulation of Nanotechnology
Because of the ongoing argument on the implications of nanotechnology, there is important debate concerning whether nanotechnology or nanotechnology-based products quality special government regulation. This mainly relates to when to evaluate new substances prior to their release into the community, market and environment. Nanotechnology refers to an cumulative number of commercially existing products – from socks and trousers to tennis racquets and cleaning cloths. Such nanotechnologies and their associated industries have triggered calls for enlarged community participation and effective regulatory arrangements.
Track 2: Regulation of Nanotechnology in Consumer Products
Nanotechnology has become global. Nanocomponents in various products are already on the market and their figure is growing fast. Within the last fourteen months the number of listed nano-products became more than double. The product record of the Woodrow Wilson Center currently lists 580 products supposed to contain nanocomponents compared to 212 in March 2007. Assuming that the numbers show a representative growth of products, we are currently facing remarkably developing market-potentials in different branches. Looking at the different kinds, the Health & Fitness sector lists 356 products and contributes with more than 60% to the whole market.
Track 3: Nano Toxicology
Nanotoxicology is the combinational study of the toxicity of nanomaterials. Due to quantum size effects and large surface area to volume ratio, nanomaterials have distinct properties compared with their larger counterparts. Nanotoxicology is a branch of bionanoscience which includes the study and application of toxicity of nanomaterials. Nanomaterials, even when prepared of inert elements like gold, become highly active at nanometer dimensions. Nanotoxicological studies are planned to determine whether and to what level these properties may pose a risk to the environment and to human beings. For example, Diesel nanoparticles have been studied to harm the cardiovascular system in a mouse model.
Track 4: Environmental Impact of Nanotechnology
The environmental impact of nanotechnology is the potential effects that the use of nanotechnological devices and materials will have on the environment. As nanotechnology is an developing field, there is great debate regarding to what extent commercial and industrial use of nanomaterials will affect organisms and ecosystems. Nanotechnology’s environmental impact can be divided into two aspects: the potential for nanotechnological revolutions to help in improvement of the environment, and the possibly novel category of pollution that nanotechnological materials might cause if released into the environment.
Track 5: Health Impact of Nanotechnology
The health impacts of nanotechnology are the potential effects that the use of nanotechnological devices and materials will have on human health. As nanotechnology is an emergent field, there is great discussion regarding to what extent nanotechnology will benefit or pose risks on human health. Nanotechnology’s health impacts can be divided into two aspects: the potential for Nano technological revolutions to have medical applications to cure disease, and the potential health hazards pretended by exposure to nanomaterials.
Track 6: Societal Impact of Nanotechnology
Beyond the toxicity hazards to human health and the environment which are related with first-generation nanomaterials, nanotechnology has wider societal impact and poses broader social challenges. Social scientists have advised that nanotechnology’s social issues should be agreed and evaluated not simply as “downstream” risks or impacts. Rather, the challenges should be factored into “upstream” research study and decision-making in the direction to certify technology development that meets social objectives.
Track 7: Risks Assessment and Management of Nanotechnology
Studies of the health effect of airborne particles usually shown that for toxic materials, smaller particles are more toxic. This is due in part to the fact that, the same mass per volume, the dose in terms of constituent part numbers rises as particle size decreases. Based on available data, it has been claimed that current risk assessment methods are not suited to the hazards related with nanoparticles; in particular, existing toxicological and eco-toxicological procedures are not up to the task; exposure evaluation needs to be conveyed as quantity of nanoparticles and surface area relatively than simply mass; tools for routine detecting and evaluating nanoparticles in air, water, soil is inadequate; and very tiny is known about the physiological replies to nanoparticles. Regulatory bodies in the U.S. as well as in the EU have determined that nanoparticles form the potential for a completely new risk and that it is essential to carry out an extensive study of the risk. The challenge for regulators is whether a matrix can be advanced which would recognize nanoparticles and more complex Nano-formulations which are expected to have special toxicological properties or whether it is more practical for each particle or formulation to be tested separately.
FOR MORE DETAILS AND REGISTRATION FOLLOW THE LINK GIVEN BELLOW: